Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


SEE Solar 2013 - Solar PV & Thermal Exhibition

29 May 2013 - 31 May 2013 - Sofia, Bulgaria



Bookmark and Share


SEE Solar 2013 - Solar PV & Thermal Exhibition

29-31 May 2013, Sofia, Bulgaria. Organizer: Via Expo

A new report from the European Photovoltaic Industry Association (EPIA) has pointed that the solar photovoltaic (PV) electricity continued its remarkable growth trend in 2011.

The solar market in South-East Europe is still small, but it is growing rapidly and it has a great potential to become a considerable part of the global renewable market.

SEE Solar Exhibition is targeted to the Region and its 2012 edition achieved a great success and gathered leading companies - manufacturers, installers, consultants and investors.

Testimonials

‘We are glad that we achieved our objectives. It is very important for us to participate in such major initiatives related to the green energy because we are convinced that ETEM has a key role in this sector in Bulgaria.’ Mr. Bulionis, ETEM Bulgaria

‘There was significant interest in the products of Hill & Smith from companies from Croatia, Italy, Romania, Czech Republic and Serbia, which contributed to the creation of useful contacts in these countries.’ Julia Koleva, Hill & Smith, Bulgaria

‘Well prepared and organized, best notes from us! Well done!’ Antonio Dzaja, Davide Gran, Heliocentris, Germany

‘The Bulgarian market is a good target for our company and we plan to work there for a long time’. Kerstin Schmidt, REC, Germany

Some Key Figures of the SEE Solar, EE & RE and ‘Save the Planet’ Exhibitions

  • 20% increase of the number of participants compared to 2011
  • Over 50 % of the exhibition area was covered by foreign companies
  • 412 exhibitors from 33 countries
  • Visitors from 47 countries
  • Austrian and USA Pavilions
  • Group Participations within projects, financed by EU funds

2013 Edition

Fronius, REFUsol GmbH, Sputnik Engineering AG (Solarmax), Diehl Ako Stiftung & CO. KG, Chinaland Solar, REC, SMA Central & Eastern Europe, etc. have already confirm their participating again.

Press Releases

Post Event Report 2012

Testimonials

Photogallery

Organiser: Via Expo

T/F+359 32 960 011, 945 459| E office@viaexpo.com| W www.viaexpo.com



Further information
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!